357 related articles for article (PubMed ID: 31084358)
1. Advanced Oxidation Protein Products Promote Lipotoxicity and Tubulointerstitial Fibrosis
Li X; Zhang T; Geng J; Wu Z; Xu L; Liu J; Tian J; Zhou Z; Nie J; Bai X
Antioxid Redox Signal; 2019 Sep; 31(7):521-538. PubMed ID: 31084358
[No Abstract] [Full Text] [Related]
2. Advanced Oxidation Protein Products Aggravate Tubulointerstitial Fibrosis Through Protein Kinase C-Dependent Mitochondrial Injury in Early Diabetic Nephropathy.
Li X; Xu L; Hou X; Geng J; Tian J; Liu X; Bai X
Antioxid Redox Signal; 2019 Mar; 30(9):1162-1185. PubMed ID: 29482336
[TBL] [Abstract][Full Text] [Related]
3. Advanced oxidation protein products activate intrarenal renin-angiotensin system via a CD36-mediated, redox-dependent pathway.
Cao W; Xu J; Zhou ZM; Wang GB; Hou FF; Nie J
Antioxid Redox Signal; 2013 Jan; 18(1):19-35. PubMed ID: 22662869
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-27a promotes renal tubulointerstitial fibrosis via suppressing PPARγ pathway in diabetic nephropathy.
Hou X; Tian J; Geng J; Li X; Tang X; Zhang J; Bai X
Oncotarget; 2016 Jul; 7(30):47760-47776. PubMed ID: 27351287
[TBL] [Abstract][Full Text] [Related]
5. Advanced oxidation protein products induce endothelial-to-mesenchymal transition in human renal glomerular endothelial cells through induction of endoplasmic reticulum stress.
Liang X; Duan N; Wang Y; Shu S; Xiang X; Guo T; Yang L; Zhang S; Tang X; Zhang J
J Diabetes Complications; 2016; 30(4):573-9. PubMed ID: 26861949
[TBL] [Abstract][Full Text] [Related]
6. CD36 promotes NLRP3 inflammasome activation via the mtROS pathway in renal tubular epithelial cells of diabetic kidneys.
Hou Y; Wang Q; Han B; Chen Y; Qiao X; Wang L
Cell Death Dis; 2021 May; 12(6):523. PubMed ID: 34021126
[TBL] [Abstract][Full Text] [Related]
7. Oridonin ameliorates renal fibrosis in diabetic nephropathy by inhibiting the Wnt/β-catenin signaling pathway.
Li J; Shu L; Jiang Q; Feng B; Bi Z; Zhu G; Zhang Y; Li X; Wu J
Ren Fail; 2024 Dec; 46(1):2347462. PubMed ID: 38832497
[TBL] [Abstract][Full Text] [Related]
8. Expression and cellular distribution of TLR4, MyD88, and NF-κB in diabetic renal tubulointerstitial fibrosis, in vitro and in vivo.
Liu P; Li F; Qiu M; He L
Diabetes Res Clin Pract; 2014 Aug; 105(2):206-16. PubMed ID: 24894085
[TBL] [Abstract][Full Text] [Related]
9. Renal tubulointerstitial fibrosis in OVE26 type 1 diabetic mice.
Powell DW; Bertram CC; Cummins TD; Barati MT; Zheng S; Epstein PN; Klein JB
Nephron Exp Nephrol; 2009; 111(1):e11-9. PubMed ID: 19052473
[TBL] [Abstract][Full Text] [Related]
10. CD36 is one of important receptors promoting renal tubular injury by advanced oxidation protein products.
Iwao Y; Nakajou K; Nagai R; Kitamura K; Anraku M; Maruyama T; Otagiri M
Am J Physiol Renal Physiol; 2008 Dec; 295(6):F1871-80. PubMed ID: 18971214
[TBL] [Abstract][Full Text] [Related]
11. Tanshinone IIA is superior to paricalcitol in ameliorating tubulointerstitial fibrosis through regulation of VDR/Wnt/β-catenin pathway in rats with diabetic nephropathy.
Zeng JY; Wang Y; Hong FY; Miao M; Jiang YY; Qiao ZX; Wang YT; Bao XR
Naunyn Schmiedebergs Arch Pharmacol; 2024 Jun; 397(6):3959-3977. PubMed ID: 37991543
[TBL] [Abstract][Full Text] [Related]
12. FOXO3a accumulation and activation accelerate oxidative stress-induced podocyte injury.
Chen X; Liu W; Xiao J; Zhang Y; Chen Y; Luo C; Huang Q; Peng F; Gong W; Li S; He X; Zhuang Y; Wu N; Liu Y; Wang Y; Long H
FASEB J; 2020 Oct; 34(10):13300-13316. PubMed ID: 32786113
[TBL] [Abstract][Full Text] [Related]
13. Complement C5a inhibition moderates lipid metabolism and reduces tubulointerstitial fibrosis in diabetic nephropathy.
Yiu WH; Li RX; Wong DWL; Wu HJ; Chan KW; Chan LYY; Leung JCK; Lai KN; Sacks SH; Zhou W; Tang SCW
Nephrol Dial Transplant; 2018 Aug; 33(8):1323-1332. PubMed ID: 29294056
[TBL] [Abstract][Full Text] [Related]
14. Advanced oxidation protein products induce G1 phase arrest in intestinal epithelial cells via a RAGE/CD36-JNK-p27kip1 mediated pathway.
Shi J; Sun S; Liao Y; Tang J; Xu X; Qin B; Qin C; Peng L; Luo M; Bai L; Xie F
Redox Biol; 2019 Jul; 25():101196. PubMed ID: 31014575
[TBL] [Abstract][Full Text] [Related]
15. FSP1-specific SMAD2 knockout in renal tubular, endothelial, and interstitial cells reduces fibrosis and epithelial-to-mesenchymal transition in murine STZ-induced diabetic nephropathy.
Loeffler I; Liebisch M; Allert S; Kunisch E; Kinne RW; Wolf G
Cell Tissue Res; 2018 Apr; 372(1):115-133. PubMed ID: 29209813
[TBL] [Abstract][Full Text] [Related]
16. CDK5 promotes renal tubulointerstitial fibrosis in diabetic nephropathy via ERK1/2/PPARγ pathway.
Bai X; Hou X; Tian J; Geng J; Li X
Oncotarget; 2016 Jun; 7(24):36510-36528. PubMed ID: 27145370
[TBL] [Abstract][Full Text] [Related]
17. Ectopic lipid accumulation: potential role in tubular injury and inflammation in diabetic kidney disease.
Yang W; Luo Y; Yang S; Zeng M; Zhang S; Liu J; Han Y; Liu Y; Zhu X; Wu H; Liu F; Sun L; Xiao L
Clin Sci (Lond); 2018 Nov; 132(22):2407-2422. PubMed ID: 30348828
[TBL] [Abstract][Full Text] [Related]
18. Advanced oxidation protein products induce chondrocyte apoptosis via receptor for advanced glycation end products-mediated, redox-dependent intrinsic apoptosis pathway.
Wu Q; Zhong ZM; Zhu SY; Liao CR; Pan Y; Zeng JH; Zheng S; Ding RT; Lin QS; Ye Q; Ye WB; Li W; Chen JT
Apoptosis; 2016 Jan; 21(1):36-50. PubMed ID: 26520447
[TBL] [Abstract][Full Text] [Related]
19. The antioxidant peptide SS31 prevents oxidative stress, downregulates CD36 and improves renal function in diabetic nephropathy.
Hou Y; Shi Y; Han B; Liu X; Qiao X; Qi Y; Wang L
Nephrol Dial Transplant; 2018 Nov; 33(11):1908-1918. PubMed ID: 30388276
[TBL] [Abstract][Full Text] [Related]
20. Ginsenoside Rg1 attenuates glomerular fibrosis by inhibiting CD36/TRPC6/NFAT2 signaling in type 2 diabetes mellitus mice.
Han Y; Su Y; Han M; Liu Y; Shi Q; Li X; Wang P; Li W; Li W
J Ethnopharmacol; 2023 Feb; 302(Pt A):115923. PubMed ID: 36375645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
